| Pulse Biosciences, Inc Common Stock (DE) | $3.9b | $47.73 | -3.9% | 463.1K | |
| Arbutus Biopharma Corporation Common Stock | $1.0b | $4.45 | -1.8% | 7.9M | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $98.4m | $0.80 | +1.7% | 389.2K | |
| Zentek Ltd. Common Stock | $85.3m | $0.49 | 0.0% | N/A | |
| Clene Inc. Common Stock | $53.4m | $4.09 | 0.0% | 56.9K | |
| NanoViricides Inc. | $29.4m | $1.27 | +1.6% | 237.9K | |
| Polyrizon Ltd. Ordinary Shares | $26.2m | $9.50 | -5.6% | 56.3K | |
| Lexaria Bioscience Corp. Common Stock | $21.8m | $2.79 | -6.8% | 76.4K | |
| Aspire Biopharma Holdings, Inc. Common Stock | $12.9m | $8.70 | +6.5% | 16.5K | |
| TransCode Therapeutics, Inc. Common Stock | $2.3m | $1.57 | +2.3% | 15.3K |